Video Topic: Google Hangouts/Ask the Expert
Spinal Cord Injury and Stem Cell-Based Trials: What’s the Latest?
In this Google Hangout, Jane Lebkowski, PhD, president of research and development at Asterias Biotherapeutics, and Kevin Whittlesey, PhD, a CIRM science officer discuss the latest progress in stem cell-based research for treatment of spinal cord injury. Asterias has a $14 million CIRM grant to support their embryonic stem cell-based clinical trial for spinal cord […]
Stem Cell Therapies for Leukemia: Marching Toward the Clinic
On March 25th, 2014, California’s Stem Cell Agency (CIRM) hosted a live Google Hangout about recent progress in stem cell based treatment strategies for leukemia. Guest experts included CIRM grantees Dr. Catriona Jamieson of UCSD and Ravi Majeti of Stanford University who discussed their CIRM-funded research projects which aim to bring stem cell based therapies […]
Diabetes: Progress toward stem cell therapies, a Live Google Hangout
California’s Stem Cell Agency (CIRM) hosted a live Google Hangout about recent progress in stem cell based strategies for diabetes therapies. The speakers included: Francisco Prieto, MD – CIRM’s diabetes patient advocate governing board member. Dr. Prieto is a practicing physician and researcher who has been active in diabetes care, patient and professional education […]
Heart disease: Progress toward stem cell therapies, a live Google Hangout
Watch this Google Hangout to learn about recent progress in developing stem cell therapies for heart disease. Hear from stem cell clinical trial participant Fred Lesikar, stem cell experts Dr. Joseph Wu (Stanford) and Dr. Bruce Conklin (Gladstone Institutes) and CIRM science officer Dr. Cathy Priest. For more information about heart disease research funded by California’s […]
Google Hangout: Progress Toward Stem Cell Therapies for ALS
On July 3rd, CIRM hosted a Google Hangout to discuss progress toward stem cell therapies for Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease. Dr. Clive Svendsen, a CIRM grantee and director of the Cedar Sinai Regenerative Medicine Institute, joined the hangout to describe his efforts to bring a stem cell based ALS […]
Parkinson’s: Ask the Stem Cell Expert | Xianmin Zeng, Buck Institute
Dr. Xianmin Zeng, associate professor at the Buck Institute for Research on Aging answers your questions about Parkinson’s disease and stem cell research. Zeng has a CIRM research grant to develop a stem cell treatment for Parkinson’s disease. Parkinson’s disease is a neurodegenerative disorder, which leads to tremors, slowness in movement, impaired balance, and stiffness. […]
Alzheimer’s Stem Cell Research: Ask the Expert – Larry Goldstein, UCSD
In this first installment of CIRM TV’s “Ask the Expert” video series, Larry Goldstein of the University of California, San Diego answers questions about finding stem cell based therapies for Alzheimer’s disease. Readers of CIRM’s Facebook, Twitter, and research blog sent in the questions over the past few weeks. Dr. Goldstein is a CIRM grantee […]
Alzheimer’s Ask the Expert video, Part 2: Of stem cells, iphones and a cellular black box
Bonus footage from the first installment of CIRM TV’s “Ask the Expert” video series in which Larry Goldstein of the University of California, San Diego answers questions about finding stem cell based therapies for Alzheimer’s disease. Readers of CIRM’s Facebook, Twitter, and research blog sent in the questions over the past few weeks. Dr. Goldstein […]
Stem Cell Therapies: Are We There Yet? – Larry Goldstein UCSD
Searching the internet for “stem cells” yields hundreds of websites from around the world promising stem cell cures for virtually every disease. Are these clinics legit? What stem cell-based therapies are available now? Larry Goldstein, director of the UC San Diego Stem Cell Program, sits down with CIRM TV to set the record straight.
Our Stem Cell Future: What’s Next? – Larry Goldstein UCSD
Larry Goldstein, director of the UC San Diego Stem Cell Program, speculates about the future of stem cell therapies.